O'Neill MJ - Search Results

1

LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.

Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ. Murray TK, et al. J Pharmacol Exp Ther. 2003 Aug;306(2):752-62. doi: 10.1124/jpet.103.049445. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730350

2

AMPA receptor potentiators for the treatment of CNS disorders.

O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. O'Neill MJ, et al. Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. doi: 10.2174/1568007043337508. Curr Drug Targets CNS Neurol Disord. 2004. PMID: 15180479 Review.

3

LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease.

O'Neill MJ, Murray TK, Clay MP, Lindstrom T, Yang CR, Nisenbaum ES. O'Neill MJ, et al. CNS Drug Rev. 2005 Spring;11(1):77-96. doi: 10.1111/j.1527-3458.2005.tb00037.x. CNS Drug Rev. 2005. PMID: 15867954 Free PMC article. Review.

4

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease.

Murray TK, Messenger MJ, Ward MA, Woodhouse S, Osborne DJ, Duty S, O'Neill MJ. Murray TK, et al. Pharmacol Biochem Behav. 2002 Sep;73(2):455-66. doi: 10.1016/s0091-3057(02)00842-0. Pharmacol Biochem Behav. 2002. PMID: 12117601

5

Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease.

O'Neill MJ, Murray TK, Whalley K, Ward MA, Hicks CA, Woodhouse S, Osborne DJ, Skolnick P. O'Neill MJ, et al. Eur J Pharmacol. 2004 Feb 20;486(2):163-74. doi: 10.1016/j.ejphar.2003.12.023. Eur J Pharmacol. 2004. PMID: 14975705

6

An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study.

Mackowiak M, O'Neill MJ, Hicks CA, Bleakman D, Skolnick P. Mackowiak M, et al. Neuropharmacology. 2002 Jul;43(1):1-10. doi: 10.1016/s0028-3908(02)00066-7. Neuropharmacology. 2002. PMID: 12213254

7

Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.

O'Neill MJ, Bond A, Ornstein PL, Ward MA, Hicks CA, Hoo K, Bleakman D, Lodge D. O'Neill MJ, et al. Neuropharmacology. 1998 Oct-Nov;37(10-11):1211-22. doi: 10.1016/s0028-3908(98)00134-8. Neuropharmacology. 1998. PMID: 9849659

8

NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus.

Bond A, Lodge D, Hicks CA, Ward MA, O'Neill MJ. Bond A, et al. Eur J Pharmacol. 1999 Sep 10;380(2-3):91-9. doi: 10.1016/s0014-2999(99)00523-3. Eur J Pharmacol. 1999. PMID: 10513567

9

Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.

Hicks CA, Ward MA, Swettenham JB, O'Neill MJ. Hicks CA, et al. Eur J Pharmacol. 1999 Sep 24;381(2-3):113-9. doi: 10.1016/s0014-2999(99)00543-9. Eur J Pharmacol. 1999. PMID: 10554878

10

Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O'Neill MF, Kingston AE, Monn JA, Ornstein PL, Schoepp DD, Lodge D, O'Neill MJ. Bond A, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):800-9. J Pharmacol Exp Ther. 2000. PMID: 10945827

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters